Cognitive Effects of Roflumilast in (a)MCI and Mild Dementia Patients

NCT04658654 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment
Mild Dementia
Amnestic Mild Cognitive Disorder

Interventions

DRUG: Roflumilast
DRUG: Placebo oral tablet

Sponsor

Maastricht University Medical Center